Rocky Vega

The financial crisis that began in housing, and then with banks and insurers, has now moved onto the balance sheets of nations. And, among the fiscally unsound, it’s the euro that is suffering the most. It recently hit a 14-month low in dollar terms, and the ongoing uncertainty facing the EU continues to break records for pessimism.

According to MarketWatch:

“In early February, the cost of insuring against a sovereign default in Western Europe exceeded the price of similar protection against default by North American investment-grade companies. That was the first time this had happened, according to data compiled by Markit from the credit derivatives market.

“The move ‘symbolizes how credit risk has been transformed from corporate to sovereign risk, as the solution to the financial and economic crisis was government intervention,’ Hans Mikkelsen, credit strategist at Bank of America Merrill Lynch, wrote in a note to investors at the time.”

But it’s not just a European problem…

“Even though the current epicenter of the crisis is focused on the euro zone, the overall fiscal position of the single currency area is stronger than that of the U.S., the U.K. and Japan, he noted.

“‘Unless there is a radical change of course by those in charge of fiscal policy in the U.S., Japan and the U.K., these countries’ sovereigns too will, sooner (in the case of the U.K.) or later (in the case of Japan and the U.S.) be at risk of being tested by the markets,’ Buiter said.”

In response to these market pressures, Greece, and now Spain and Portugal, have begun austerity programs to rein in government spending and get deficits under control. As Daily Reckoning editorial director Eric Fry recently pointed out in the chart below, the US has similar debt funding requirements as the troubled EU countries… but has yet to start acting like the party’s over.

Visit MarketWatch to read more details on the second debt storm.

Best,

Rocky Vega,
The Daily Reckoning

Rocky Vega

Rocky Vega is publisher of Agora Financial International, where he advances the growth of Agora Financial publishing enterprises outside of the US. Previously, he was publisher of The Daily Reckoning, and founding publisher of both UrbanTurf and RFID Update -- which he ran from Brazil, Chile, and Puerto Rico -- as well as associate publisher of FierceFinance. Rocky has an honors MS from the Stockholm School of Economics and an honors BA from Harvard University, where he served on the board of directors for Let?s Go Publications, Harvard Student Agencies, and The Harvard Advocate.

  • Eamon

    This is already baked into the cake…such is the way within the Money Masters’ completely rigged kleptocracy. Maybe the Mogambo has some extra space in his Bunker of Paranoid Seclusion?

  • Pingback: Love Letters For Him()

  • Pingback: Trackback()

  • Pingback: Trackback()

  • Pingback: Trackback()

Recent Articles

One Last Ditch Effort To Agree

Chuck Butler

Chuck Butler discusses the stimulus in China and what he sees are the differences, plus details as Greece arrives in Brussels with their latest proposal for an agreement. All that and more in today's Daily Pfennig...


A Tale of Two Crises

James Rickards

Jim Rickards updates his "There Will Be No 'Grexit'" thesis as two stories dominate global financial headlines. Find out why global capital markets are a tale of two crises.


The Medicine of the Future Is You

Stephen Petranek

The most promising and exciting advance in all the history of medicine is upon us, and yet it is actually not new at all — it’s as old as humans. The advance? Our immune systems. Stephen Petranek has more on how immunotherapy could change the way we treat cancer


Rick Rule: Some of the Best Oil Plays Are in “Midstream” Stocks

Henry Bonner

With the oil sector cruising in low gear since last year’s price collapse, should you be investing in oil companies? Yes, according to our friends at Sprott, Henry and Rick — especially if you look at mid-stream companies, which move oil from point A to point B. Since oil moves no matter the price, they make money no matter the price!


Greece Saved the Biotech Bull Market!

Greg Guenthner

Just a few days ago, I noticed that 70 biotech stocks were in the green on the week -- a week where almost every single S&P component was in the red on Monday afternoon. So we hitched our wagon to health care stocks. And these stocks have remained strong in the face of a hurricane of negative news hitting the airwaves.